Alert Done Done Edit In progress Play Run workshop Download Down Close All modules Educator In progress Learner How to Delete Information Credits Undo Time Left Right Right Down Locked Hide Home Menu Twitter LinkedIn icons.facebook Plus

IgAN: Pathogenesis and pathophysiology

IgA nephropathy (IgAN) is a leading cause of chronic kidney disease and the most common glomerular disease worldwide. But its pathogenesis has not yet been fully elucidated, leaving some questions so far unanswered. In this video, Dr Richard Lafayette presents an overview of our current understanding of how this disease develops and presents.

By completing this module you can qualify for 0.25 CME credits. To claim your credits, you must watch the video and successfully pass the post-module assessment.

Pre-Activity Information

Magnifying glass

Nephrologists

Checklist

After taking part in this activity, learners will be able to: 

  1. Describe the need for suspicion of IgAN, as well as its pathogenesis and pathophysiology
Faculty

Faculty: Dr. Richard Lafayette

Type of affiliation / financial interest Name of commercial company
Research Travere, Omeros, Calliditas, Vera, Otsuka/Visterra
Consulting Travere, Omeros, Calliditas, Vera, Otsuka/Visterra

Staff Disclosures

Liberum IME staff, ACHL staff and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

 

The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity.

Hand with money

This independent educational activity is supported by an educational grant from Travere Therapeutics. The educational content has been developed by Liberum IME and validated by an independent steering committee; Travere Therapeutics has had no influence on the content of this education. 

This module was accredited on the 1st March 2022 and will expire on the 1st March 2023.

The information and data provided in this program was updated and correct at the time of the program development, but may be subject to change.

Video

Accreditation Expired

Dr. Richard Lafayette

IgAN: Pathogenesis and pathophysiology

Global

An overview of the latest understanding of the pathogenesis and pathophysiology of IgAN